Vitro Biopharma Appoints Established Life Science Sales Executive to its Board of Directors

Golden, Colorado—February 20, 2013—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, simultaneously accepted the resignation of Mr. Erik Van Horn from its Board of Directors and appointed Pete Shuster, the CEO of Neuromics, Inc. to its Board of Directors.  Mr. Shuster is a seasoned and experienced sales executive.  He is the current owner of Neuromics, Inc., a privately held and profitable business focused on sales of numerous (>2500) specialty life science products including stem cell products manufactured by Vitro Biopharma.  Neuromics, Inc. sales have grown over 5.5-fold since inception in 2003.  Shuster has extensive prior experience in managing sales of computer software and related products for companies including Caterpillar, Baxter Healthcare and Harley-Davidson.

Mr. Erik Van Horn has also resigned from Vitro Biopharma’s Board of Directors due to the request of his present employer.  Vitro Biopharma is presently engaged in expansion of sales of its stem cell...

Vitro Biopharma, Inc

Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG; http://www.vitrobiopharma.com), owns US patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in tr...

View more


  CONTACT  
  • Dr. James Musick
  • Chief Executive Officer
  • (303) 999-2130 3
  •